Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - NAC GLOBAL TECHNOLOGIES, INC.Financial_Report.xls
EX-32 - 906 CERTIFICATION - NAC GLOBAL TECHNOLOGIES, INC.ex32.htm
EX-31 - 302 CERTIFICATION OF SHELLEY GOFF - NAC GLOBAL TECHNOLOGIES, INC.ex312.htm
EX-31 - 302 CERTIFICATION OF THOMAS J. HOWELLS - NAC GLOBAL TECHNOLOGIES, INC.ex311.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

____________________

  

FORM 10-Q

____________________

    

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934

  

For the quarterly period ended September 30, 2011

  

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE EXCHANGE ACT

  

For the transition period from ____________ to____________

  

Commission File No. 000-49655

  

LIPIDVIRO TECH, INC.

(Exact name of registrant as specified in its charter)


Nevada

87-0678927

(State or other jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

  


4685 S. Highland Drive, Suite #202

Salt Lake City, Utah  84117

(Address of principal executive offices)


(801) 278-9424

(Registrant’s telephone number, including area code)


N/A

(Former name, former address and former fiscal year,

if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]


Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [  ].  The Company does not have a corporate Web site.


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):


Large accelerated filer   [  ]                                                     Accelerated filer [  ]

Non-accelerated filer     [  ]                                                     Smaller reporting company  [X]

(Do not check if a smaller reporting company)




1





Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [X] No [  ]


APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS


Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.


Not applicable.


APPLICABLE ONLY TO CORPORATE ISSUERS


Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: October 17, 2011 - 1,305,344 shares of common stock.


PART I


Item 1.  Financial Statements


The financial statements of LipidViro Tech, Inc., a Nevada corporation (the “Company,” “we,” “our” or “us”), required to be filed with this 10-Q Quarterly Report were prepared by management and commence below, together with related notes. In the opinion of management, the financial statements fairly present the financial condition of the Company.







2




LIPIDVIRO TECH, INC.

(A Development Stage Company)


SEPTEMBER 30, 2011 UNAUDITED CONDENSED FINANCIAL STATEMENTS



TABLE OF CONTENTS


 

PAGE

Unaudited Condensed Balance Sheets, September 30, 2011 and December 31, 2010

4

 

 

Unaudited Condensed Statements of Operations, For the Three-Month and Nine-Month Periods

Ended September 30, 2011 and 2010 and For the Period From Inception On May 6, 2003

Through September 30, 2011

5

 

 

Unaudited Condensed Statements of Cash Flows, For the Nine-Month Periods Ended September 30, 2011

and 2010 and For the Period From Inception On May 6, 2003 Through September 30, 2011

6

 

 

Notes to the Unaudited Condensed Financial Statements

7 – 9

 

 




3




LIPIDVIRO TECH, INC.

(A Development Stage Company)

CONDENSED BALANCE SHEETS


ASSETS


 

September 30, 2011

(Unaudited)

 

December 31, 2010

(Audited)

CURRENT ASSETS:

 

 

 

 

 

Current Deferred Tax Asset

$

0

 

$

8,850

Total Current Assets

 

0

 

 

8,850

TOTAL ASSETS

$

0

 

$

8,850

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Accounts payable

$

102,504

 

$

195,035

Related party loans

 

140,743

 

 

106,709

Total Current Liabilities

 

243,247

 

 

301,744

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY (DEFICIT):

 

 

 

 

 

Common stock, $0.001 par value, 150,000,000 shares authorized, 1,305,344 shares issued and outstanding

 

1,305

 

 

1,305

Capital in excess of par value

 

4,852,612

 

 

4,852,612

Deficit accumulated during the development stage

 

(5,097,164)

 

 

(5,146,811)

Total Stockholders’ Equity (Deficit)

 

(243,247)

 

 

(292,894)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

$

0

 

$

8,850





























The accompanying notes are an integral part of these unaudited condensed financial statements.



4




LIPIDVIRO TECH, INC.

(A Development Stage Company)

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS


 

For the Three-Month Periods Ended September 30,

 

For the Nine-Month Periods Ended September 30,

 

For the Period From Inception on May 6, 2003 Through September 30, 2011

 

2011

 

2010

 

2011

 

2010

 

REVENUE

$

0

 

$

0

 

$

0

 

$

0

 

$

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consulting

 

0

 

 

0

 

 

0

 

 

0

 

 

564,269

Employee compensation

 

0

 

 

0

 

 

0

 

 

0

 

 

322,598

Professional fees

 

2,941

 

 

3,940

 

 

17,596

 

 

18,437

 

 

434,316

Other general and administrative

 

1,000

 

 

0

 

 

1,650

 

 

212

 

 

103,318

Total Operating Expenses

 

3,941

 

 

3,940

 

 

19,246

 

 

18,649

 

 

1,424,501

OPERATING LOSS

 

(3,941)

 

 

(3,940)

 

 

(19,246)

 

 

(18,649)

 

 

(1,424,501)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on settlement of debt

 

0

 

 

0

 

 

85,401

 

 

0

 

 

121,808

Related party interest expense

 

(2,769)

 

 

(2,010)

 

 

(7,658)

 

 

(5,583)

 

 

(1,586,892)

Total Other Income (Expense)

 

(2,769)

 

 

(2,010)

 

 

77,743

 

 

(5,583)

 

 

(1,465,084)

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

(6,710)

 

 

(5,950)

 

 

58,497

 

 

(24,232)

 

 

(2,889,585)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PROVISION FOR INCOME TAXES

 

0

 

 

0

 

 

(8,850)

 

 

0

 

 

0

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

(6,710)

 

 

(5,950)

 

 

49,647

 

 

(24,232)

 

 

(2,889,585)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DISCONTINUED OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations of discontinued research business

 

0

 

 

0

 

 

0

 

 

0

 

 

(2,207,579)

Income tax expense

 

0

 

 

0

 

 

0

 

 

0

 

 

0

LOSS FROM DISCONTINUED OPERATIONS

 

0

 

 

0

 

 

0

 

 

0

 

 

(2,207,579)

NET INCOME (LOSS)

$

(6,710)

 

$

(5,950)

 

$

49,647

 

$

(24,232)

 

$

(5,097,164)

BASIC AND DILUTED INCOME (LOSS) PER SHARE

$

(0.01)

 

$

(0.00)

 

$

0.04

 

$

(0.02)

 

 

 

WEIGHTED AVERAGE SHARES OUTSTANDING

 

1,305,344

 

 

1,305,344

 

1,305,344

 

1,305,344

 

 

 










The accompanying notes are an integral part of these unaudited condensed financial statements.



5





LIPIDVIRO TECH, INC.

(A Development Stage Company)

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS


 

 

 

For the Period From Inception on May 6, 2003 Through September 30, 2011

 

For the Nine-Month Periods Ended September 30,

 

 

2011

 

2010

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net income (loss)

$

49,647

 

$

(24,232)

 

$

(5,097,164)

Adjustments to reconcile net income (loss) to net cash used by operating activities:

 

 

 

 

 

 

 

 

Gain on extinguishment of debt

 

(85,401)

 

 

0

 

 

(371,890)

Noncash expenses

 

0

 

 

0

 

 

4,131,910

Decrease in current deferred tax asset

 

8,850

 

 

0

 

 

0

Increase (decrease) in accounts payable

 

(7,130)

 

 

5,819

 

 

337,385

Increase in related party accrued interest

 

7,658

 

 

5,583

 

 

198,345

Net Cash Used by Operating Activities

 

(26,376)

 

 

(12,830)

 

 

(801,414)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Cash of LTU at disposal

 

0

 

 

0

 

 

(25)

Payments for property and equipment

 

0

 

 

0

 

 

(3,675)

Payments for definite-life intangible assets

 

0

 

 

0

 

 

(33,632)

Payments for goodwill

 

0

 

 

0

 

 

(269,006)

Net Cash Used by Investing Activities

 

0

 

 

0

 

 

(306,338)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Proceeds from related party loans

 

26,376

 

 

12,830

 

 

750,109

Payments on related party loans

 

0

 

 

0

 

 

(8,700)

Proceeds from capital contributions

 

0

 

 

0

 

 

34,133

Proceeds from common stock issuances

 

0

 

 

0

 

 

293,700

Proceeds from sale of warrants

 

0

 

 

0

 

 

38,510

Net Cash Provided by Financing Activities

 

26,376

 

 

12,830

 

 

1,107,752

NET INCREASE (DECREASE) IN CASH

 

0

 

 

0

 

 

0

 

 

 

 

 

 

 

 

 

CASH AT BEGINNING OF PERIOD

 

0

 

 

0

 

 

0

CASH AT END OF PERIOD

$

0

 

$

0

 

$

0

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid during the period for:

 

 

 

 

 

 

 

 

Interest

$

0

 

$

0

 

$

0

Income taxes

$

0

 

$

0

 

$

0

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:

Liabilities settled by disposition of LTU with $25 in cash, $282 in net property and equipment, $290,317 in goodwill, and $19,074 in accounts payable at the time of disposition

$

0

 

$

0

 

$

1,209,297

Liabilities settled by transferring patents of $34,637

$

0

 

$

0

 

$

284,719

Definite-life intangible asset fees accrued in accounts payable

$

0

 

$

0

 

$

1,005

Deferred financing costs paid through issuance of common stock

$

0

 

$

0

 

$

31,900

Common stock repurchased through issuance of $600,000 note payable and $1 paid by a shareholder

$

0

 

$

0

 

$

600,001

Common stock issued to purchase minority interest

$

0

 

$

0

 

$

21,311


The accompanying notes are an integral part of these unaudited condensed financial statements.



6




LIPIDVIRO TECH, INC.

(A Development Stage Company)

NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS


NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X.  In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2011 and 2010 and for the periods then ended have been made.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted.  Management suggests these condensed financial statements be read in conjunction with the December 31, 2010 audited financial statements and notes thereto included in the Company’s Form 10-K.  The results of operations for the periods ended September 30, 2011 and 2010 are not necessarily indicative of the operating results for the full year.


Reclassification – Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.


NOTE 2 – GOING CONCERN


The Company’s financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  At September 30, 2011, the Company had no revenue-generating activities, had negative cash flows from operating activities, and had current liabilities in excess of current assets.  These factors create an uncertainty about the Company’s ability to continue as a going concern.  In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of common stock.  There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations.  The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.


NOTE 3 – SETTLEMENT OF DEBT


In February 2011, the Company settled accounts payable totaling $95,401 through shareholder payments totaling $10,000, resulting in a $85,401 gain on settlement of debt.


NOTE 4 – INCOME TAXES


At September 30, 2011, the Company has a net operating loss carryover of approximately $80,000 available to offset future federal taxable income and expiring in 2028 and 2029.  If there are future substantial changes in the Company’s ownership, there may be limitations on the amount of net operating loss carryovers that can be utilized.  During the nine-month period ended September 30, 2011, the Company had a gain on settlement of debt, which resulted in taxable income of $58,497.  The Company utilized net operating loss carryovers to offset the taxable income.  All tax years starting with 2008 are open for examination.


The income tax provision consists of the following components:


 

For the Nine-Month Periods Ended September 30,

 

For the Period From Inception

on May 6, 2003 Through September 30, 2011

 

2011

 

2010

 

Current income tax expense (benefit)

$

0

 

$

0

 

$

0

Benefit of net operating loss carryovers

 

8,775

 

 

0

 

 

9,804

Change in beginning valuation allowance

 

75

 

 

0

 

 

(9,804)

Net income tax expense (benefit) from continuing operations

$

8,850

 

$

0

 

$

0






7




LIPIDVIRO TECH, INC.

(A Development Stage Company)

NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS


NOTE 4 – INCOME TAXES [Continued]


The income tax provision differs from the amounts that would be obtained by applying federal statutory income tax rates to income (loss) from continuing operations before income taxes as follows:


 

For the Nine-Month Periods Ended September 30,

 

For the Period From Inception on May 6, 2003 Through September 30, 2011

 

2011

 

2010

 

Income (loss) before income tax provision

$

58,497

 

$

(24,232)

 

$

(2,889,585)

Expected federal income tax rate

 

15.0%

 

 

15.0%

 

 

15.0%

Expected income tax expense (benefit) at statutory rates

 

8,775

 

 

(3,635)

 

 

(433,437)

Tax effect of:

 

 

 

 

 

 

 

 

Limitation of prior NOL carryovers

 

0

 

 

0

 

 

47,271

Meals and entertainment

 

0

 

 

0

 

 

128

Non-deductible expenses

 

0

 

 

0

 

 

374,026

Change in valuation allowance

 

75

 

 

3,635

 

 

12,012

Net income tax expense (benefit)

$

8,850

 

$

0

 

$

0


The Company’s deferred tax assets, deferred tax liabilities, and valuation allowance are as follows:


 

September 30, 2011

 

December 31, 2010

Deferred tax assets:

 

 

 

 

 

Net operating loss carryovers

$

12,012

 

$

20,787

Total deferred tax assets

$

12,012

 

$

20,787

 

 

 

 

 

 

Deferred tax liabilities

$

0

 

$

0

Total deferred tax liabilities

$

0

 

$

0

 

 

 

 

 

 

Total deferred tax assets

$

12,012

 

$

20,787

Total deferred tax liabilities

 

0

 

 

0

Valuation allowance

 

(12,012)

 

 

(11,937)

Net deferred tax asset (liability)

$

0

 

$

8,850


These amounts have been presented in the financial statements as follows:


 

September 30, 2011

 

December 31, 2010

Current deferred tax asset (liability)

$

0

 

$

8,850

Non-current deferred tax asset (liability)

 

0

 

 

0

 

$

0

 

$

8,850


NOTE 5 – RELATED PARTY TRANSACTIONS


Related Party Loans – During the nine-month period ended September 30, 2011, shareholders or entities controlled by them loaned $26,376 to the Company.  During the nine-month periods ended September 30, 2011 and 2010, respectively, the Company accrued interest expense on related party loans totaling $7,658 and $5,583.


On July 14, 2011, the Company entered into an Agreement with Shelley Goff, the Company’s Treasurer and director, by which Ms. Goff agreed to provide XBRL services in connection with the Company’s  periodic reports.  Ms. Goff will provide XBRL services to the Company for a fee of $2,500 annually, which are the same terms under which Ms. Goff has contracted to provide similar services to other non-affiliated SEC filers through her business where she prepares documents for EDGAR filing with the Securities and Exchange Commission.




8




LIPIDVIRO TECH, INC.

(A Development Stage Company)

NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS


NOTE 6 – SUBSEQUENT EVENTS


The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are no items to disclose.








9




Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.


Forward-looking Statements


Statements made in this Quarterly Report which are not purely historical are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and our business, including, without limitation, (i) our ability to raise capital, and (ii) statements preceded by, followed by or that include the words “may,” “would,” “could,” “should,” “expects,” “projects,” “anticipates,” “believes,” “estimates,” “plans,” “intends,” “targets” or similar expressions.


Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond our control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following, general economic or industry conditions, nationally and/or in the communities in which we may conduct business, changes in the interest rate environment, legislation or regulatory requirements, conditions of the securities markets, our ability to raise capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, other economic, competitive, governmental, regulatory and technical factors affecting our current or potential business and related matters.


Accordingly, results actually achieved may differ materially from expected results in these statements.  Forward-looking statements speak only as of the date they are made.  We do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.


Plan of Operation


Our plan of operation for the next 12 months is to: (i) consider guidelines of industries in which we may have an interest; (ii) adopt a business plan regarding engaging in the business of any selected industry; and (iii) to commence such operations through funding and/or the acquisition of a going concern engaged in any industry selected.


Results of Operations


During the quarterly period ended September 30, 2011, we received no revenue and incurred operating expenses of $3,941, of which $2,941 was professional fees and $1,000 was general and administrative expense.  We accrued $2,769 in related party interest expense during the quarter, for loss from continuing operations before income taxes of $6,710.  After provision for income taxes of $0, net loss for the quarterly period totaled $6,710, or $0.01 per share.  During the quarter ended September 30, 2010, we had a net loss of $5,950, or $0.00 per share.


During the nine months ended September 30, 2011, we received no revenue and incurred operating expenses of $19,246, of which $17,596 was professional fees and $1,650 was general and administrative expense.  In February, 2011, we settled accounts payable totaling $95,401 through shareholder payments totaling $10,000, resulting in a $85,401 gain on settlement of debt.  We accrued $7,658 in related party interest expense during the nine months ended September 30, 2011, for income from continuing operations before income taxes of $58,497.  After provision for income taxes of $8,850, net income for the nine months ended September 30, 2011 totaled $49,647, or $0.04 per share.  During the nine months ended September 30, 2010, we had a net loss of $24,232, or $0.02 per share.


Liquidity and Capital Resources


As of September 30, 2011, we had no cash on hand.  During the nine months ended September 30, 2011, we received related party loans of $26,376 to pay our expenses, and at September 30, 2011, we owed a total of $140,743 to related parties, all of which accrues interest at 8% per annum and is due on demand.


On July 14, 2011, the Company entered into an Agreement with Shelley Goff, the Company’s Treasurer and director, by which Ms. Goff agreed to provide XBRL services in connection with the Company’s periodic reports.  Ms. Goff will provide XBRL services to the Company for a fee of $2,500 annually, which are the same terms under which Ms. Goff has contracted to provide similar services to other non-affiliated SEC filers through her business where she prepares documents for EDGAR filing with the Securities and Exchange Commission.


During the next 12 months, our only foreseeable cash requirements will relate to the payment of our Securities and Exchange Commission and Exchange Act reporting filing expenses, including the expenses associated with Ms. Goff’s



10




services as outlined above, as well as associated legal and accounting fees; costs incident to reviewing or investigating any potential business venture; and maintaining our good standing as a corporation in the state of Nevada.  We anticipate that these funds will be provided to us in the form of loans from Jenson Services, of which our President, Thomas J. Howells, is the Secretary/Treasurer and a director.  There are no written agreements requiring Jenson Services to provide these cash resources; and to the extent funds are provided, such funds will bear interest of 8% and will be due on demand.  As of the date of this Quarterly Report, we have not actively begun to seek any business or acquisition candidate.  


Item 3.  Quantitative and Qualitative Disclosures About Market Risk.


Not required.


Item 4.  Controls and Procedures.


Evaluation of disclosure controls and procedures


Our management, with the participation of our chief executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q.  In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.  In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.  The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.


Based on that evaluation, our chief executive officer and principal financial officer concluded that, as of September 30, 2011, our disclosure controls and procedures were, subject to the limitations noted above, effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules, regulations and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.


Changes in internal control over financial reporting


Our management, with the participation of the chief executive officer and principal financial officer, has concluded there were no significant changes in our internal controls over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION


Item 1. Legal Proceedings.


None; not applicable.


Item 1A.  Risk Factors.


Not required.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


None; not applicable.


Item 3. Defaults Upon Senior Securities.


None; not applicable.


Item 4. (Removed and Reserved).



11





Item 5. Other Information.


None; not applicable.


Item 6. Exhibits.


Exhibit No.                         Identification of Exhibit


31.1

Certification of Thomas J. Howells Pursuant to Section 302 of the Sarbanes-Oxley Act.

 

 

31.2

Certification of Shelley Goff Pursuant to Section 302 of the Sarbanes-Oxley Act.

 

 

32

Certification of Thomas J. Howells and Shelley Goff pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act.

 

 

101.INS

XBRL Instance Document*

 

 

101.PRE.

XBRL Taxonomy Extension Presentation Linkbase*

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase*

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase*

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase*

 

 

101.SCH

XBRL Taxonomy Extension Schema*


*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed “furnished” and not “filed” or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, or deemed “furnished” and not “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under these sections.


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

  

LIPIDVIRO TECH, INC.


Date:

October 28, 2011

 

By:

/s/Thomas J. Howells

 

 

 

 

Thomas J. Howells, President, Chief Executive Officer and Director

 

 

 

 

 

Date:

October 28, 2011

 

By:

/s/Shelley Goff

 

 

 

 

Shelley Goff, Treasurer and Director




12